While the rise of GLP-1 receptor agonists (like Ozempic and Wegovy, both name-brand medications for semaglutide manufactured by Novo Nordisk) has made the discussion around obesity as a chronic disease, more popular and it has also caused more persons to access the drug from persons who may not be experts in obesity treatment
Investment Strategy: Modeling MFP Contagion Effects Institutional investors and sell-side analysts should build MFP contagion scenarios into revenue models for any drug with significant Medicare exposure that is approaching its negotiation eligibility window
Patients in Beverly Hills often want a provider that combines professionalism, comfort, flexibility, and a strong clinical foundation
As more people take Wegovy for weight loss, more people will experience the serious side effects related to the drug
Whitehead, A., Beck, E., Tosh, S., et al
Pharmacological prevention of diabetic cataract